Local News Immunology Institute Founded by Paul Allen Shifts Focus to Tackle Coronavirus The Seattle Times | August 19, 2020 When Microsoft co-founder Paul Allen put up $125 million in seed money for a Seattle institute focused…emcguinnAugust 19, 2020 Read More
Local News Could Treatments Aimed at Alzheimer’s Disease Help Combat COVID-19? Allen Institute | August 18, 2020 Mukesh K. Jain, M.D., remembers the exact moment that COVID-19 complications clicked into focus for…emcguinnAugust 18, 2020 Read More
Local News 5 Cool Things Your Immune System Can Do Allen Institute for Immunology | August 17, 2020 Like many things in life that we take for granted, we tend to notice our…emcguinnAugust 17, 2020 Read More
Local News The Power of Touchscreens: ISB Researchers Develop Game to Help Students Learn Molecular Biology Institute for Systems Biology | August 14, 2020 Pop quiz: What’s the difference between DNA, RNA and proteins? If you’re racking your brain to…emcguinnAugust 14, 2020 Read More
Local News Tasmanian Devil Research Offers New Insights for Tackling Cancer in Humans Washington State University | August 14, 2020 A rare, transmissible tumor has brought the iconic Tasmanian devil to the brink of extinction,…emcguinnAugust 14, 2020 Read More
Local News The McLaughlin Lab Prioritizes Curiosity, Putting Basic Science First Pacific Northwest Research Institute | August 13, 2020 PNRI scientists ask questions, pursue their curiosity, and practice basic, fundamental science. Rick McLaughlin, PhD and…emcguinnAugust 13, 2020 Read More
Local News Seattle Genetics Achieves Milestone Payment Under Antibody-Drug Conjugate Collaboration with GlaxoSmithKline Triggered by BLENREP FDA Approval Seattle Genetics via Businesswire | August 13, 2020 Seattle Genetics, Inc. (Nasdaq:SGEN) today announced U.S. Food and Drug Administration (FDA) approval of GlaxoSmithKline’s…emcguinnAugust 13, 2020 Read More
Local News Seattle Researchers ‘Excited’ by Initial Results of COVID-19 Immunotherapy Trial King5 via IDRI | August 12, 2020 A Seattle nonprofit says early results are positive on a clinical trial for immunotherapy on…emcguinnAugust 12, 2020 Read More
Local News NIH Grants $1.44M to Cancer Targeted Technology to Support the Ongoing Prostate Cancer Clinical Trial of a Promising New Radiotherapeutic, CTT1403 Cancer Targeted Technology via Businesswire | August 12, 2020 Cancer Targeted Technology (CTT), a privately-held Seattle-based biotechnology company, announced that the NIH awarded CTT…emcguinnAugust 12, 2020 Read More
Local News Color-Coding Technology Reveals New Insights about Stem Cell Biology Institute for Stem Cell & Regenerative Medicine, UW | August 11, 2020 Several years ago, Danny El-Nachef was given a task. His mission: create a tool to…emcguinnAugust 11, 2020 Read More